Amgen Inc. reports $10.37 billion revenue for quarter ended September 30, 2026, up 8.5%

ยท AMGN

Amgen Inc. reported revenue of $10.37 billion for the quarter ended September 30, 2026, an increase of 8.5% from the same quarter a year earlier ($9.56 billion).

For the same period it posted net income of $3.86 billion, up 20.1%, or $7.08 per diluted share (5.93 a year earlier).

That is a net margin of 37.3%.

On Sanad's AAOIFI Standard 21 screen, Amgen Inc. is currently compliant: interest-bearing debt is 21.8% of market capitalisation (limit 30%), and impure income is 1.1% of revenue (limit 5%).

Source: 10-Q filed with the U.S. Securities and Exchange Commission on November 4, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.

More Amgen Inc. news